(Q68100398)

English

Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin

scientific article published on 01 January 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C Fournier

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

B Hecquet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

G Bastian

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

D Khayat

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

461-466

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

https://scigraph.springernature.com/pub.10.1007/bf00684848

0 references

Combined floxuridine and cisplatin in a fourteen day infusion. Phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin and continuous infusion 5-fluorouracil for advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Palliative chemotherapy of epidermoid carcinoma of the upper respiratory and digestive tracts with a combination of carboplatin and 5-fluorouracil]

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro interactions of TNO6 with human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III randomised trial of cistplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of the binding interactions of cis-diamminedichloroplatinum(II) with amines and nucleosides by nitrogen-15 nuclear magnetic resonance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stability-indicating high-performance liquid chromatographic method for the simultaneous determination of cisplatin and 5-fluorouracil in 0.9% sodium chloride for injection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistry

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials with fluorinated pyrimidines in patients with head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical antitumor and toxicologic profile of carboplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The reaction of Pt-antitumor drugs with selected nucleophiles. I. The reaction of cis-[Pt(NH3)2Cl2] with glycine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro plasma binding of some second generation antitumor platinum complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/1568289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00684848

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1568289%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68100398&oldid=1755738271"